GINGER DAVIS: Open Payments
NPI 1427833789 · HENDERSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 62 payments from 16 companies in 2025. Trend: 2023 $260 · 2024 $608 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $265 |
| Otsuka America Pharmaceutical, Inc. | 7 | $149 |
| Novo Nordisk Inc | 7 | $136 |
| Xeris Pharmaceuticals, Inc. | 2 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Lilly USA, LLC | 4 | $81 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
Products named: REXULTI, QULIPTA, KEVEYIS, AUSTEDO XR, Wegovy, BREZTRI, VOQUEZNA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
